Understanding Regulatory and Market Needs
CELS Members: Use code "CELSVIP" for free registration
You have an idea of how your technology can improve healthcare, however, the road to market has curves you need to successfully maneuver. There are important regulatory and market considerations you need to understand and prepare for early in the development cycle.
In this forum, you will hear from a successful Canadian startup using a smartphone app to improve wound care followed by a panel of regulatory and investment professionals that will help you understand:
- Regulatory hurdles and opportunities in the Health Tech space
- The importance of current workflows and standards of care
- Investor insights - what interests them, why and where they are looking to invest
- Raising Health Tech funds in the Valley
- Upcoming changes in the FDA approach to regulating digital health and implications for device companies.
Canadian Start-Up Showcase:
Swift Medical https://swiftmedical.com/
This CELS forum is brought to you by Johnson and Johnson Innovation, JLABS and MaRS. Follow us on LinkedIn and Twitter and for more information, please visit www.cels-sfo.com
3:00 PM | Registration and networking
3:30 PM | Presentation, Carlo Perez, Swift Medical
4:00 PM | Panel Discussion, Health Tech Regulatory and Investment Panel Q&A
5:00 PM | Networking Session
6:00 PM | Program Close
NOTE: Virtual Guests - The event will be available in a webinar format with Q&A questions submitted by chat mode
Ali Farahanchi | Vice President | DHVC (Danhua Capital)
Ali is investor with DHVC, an early-stage tech and life science fund in Palo Alto. With more than $650M assets under management and 100+ companies in its portfolio, DHVC invests in variety of areas in healthcare including therapeutics, diagnostics and tools, and digital health, with strong emphasis on novel mechanisms and data-driven platforms. Previously Ali has worked in research and in consulting roles in semiconductor and healthcare industries, and has obtained graduate degrees in engineering and management from MIT and University of Chicago.
Carlo Perez | Founder & CEO | Swift Medical
Carlo Perez is an engineer and entrepreneur, passionate about delivering designs and transformative technologies that put empathy into action. Raised by a father who was a trained engineer and a mother who worked as a nurse, Carlo spent seven years in R&D at Advanced Micro Devices (AMD) Inc., where his research focused on industry-leading 3D graphics hardware. In 2009, after a year of hitchhiking, Carlo found a calling teaching post-graduate engineering at Humber College, covering subjects that ranged from RF technology to advanced robotics. During this time, he explored novel applications of state-of-the-art visioning technology with his future Swift Medical co-founders – a path that led them to wound care. Today, after three short years, Swift Medical is the category leader in digital wound care management, adopted by over 1,000 facilities to monitor over 100,000 beds across North America.
Geetha Rao | CEO | Springborne Life Sciences
Entrepreneur, executive, and strategic advisor to medical device, healthcare, and philanthropic organizations, addressing issues for high-risk technologies, including medical devices, health IT, and connected health systems. Particular focus on agile quality management and compliance strategy for rapid commercialization.
Internationally recognized expert in risk management and serve on international standards and policy making bodies. Addressed numerous industry forums and the press on issues of emerging health technologies and innovation trends, especially for connected medical technologies.
Scott Barclay | Partner | DCVC
Scott Barclay is a Partner at Data Collective- a billion dollar early-stage deep compute venture capital fund- where he leads the Computational Care practice.
Computational Care is DCVC’s deep data thesis applied to the patient journey and all aspects of the provision of care, almost always with a combination of deep compute, evidence, and empathy.
Scott is based in Palo Alto and invests globally.
As examples, Scott has invested in or sits on the board of:
- Swift Medical- machine vision to wound care at bedside
- Karius- hypothesis-free infectious disease testing
- MIC- deep compute in ICU
- Subtle Medical- deep learning applied to imaging efficiency
- Alpha Medical- full-stack digital clinic
- Enzyme- FDA submission and compliance as a service
- SafelyYou- machine vision in elder care
- Noteworth- platform for prescribing sensors and biomarkers
Scott is also part of DCVCs Computational Bio practice (Freenome, Recursion, 3Scan, Cofactor) and invests in the tech stack and against global risk (ElementAI, Cape Analytics, BlueTalon).
By background, Scott has been a founder, a serial angel investor (naviHealth, Syapse, Carelinx, Lumiata, etc), and a large company executive. Scott helped create and scale the first massive digital health platform- Surescripts- and served CVS Health as a GM and innovation leader across the company's healthcare and retail assets.
Earlier Scott worked for the Boston Consulting Group (BCG) and started a capital markets desk in London for Banc of America Securities. Scott received an MBA from INSEAD in Fontainebleau France and was militantly liberal arts and math and science at the University of Virginia.a football quarterback and manufacturing floor worker in his small Virginia town.